CHARM Therapeutics

About:

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

Website: https://charmtx.com/

Twitter/X: CHARMTherapeutx

Top Investors: Khosla Ventures, General Catalyst, NVentures, F-Prime Capital, OrbiMed

Description:

CHARM Therapeutics delivers transformational medicines through 3D deep learning and cutting-edge drug discovery technologies. It delivers transformational medicines through 3D deep learning and cutting-edge drug discovery technologies to help doctors in treating undruggable disease targets.

Total Funding Amount:

$82.7M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2021-01-01

Contact Email:

laksh(AT)charmtx.com

Founders:

David Baker, Laksh Aithani

Number of Employees:

11-50

Last Funding Date:

2023-04-14

IPO Status:

Private

© 2024 MyAiNote.com